Increase in Clorox Holdings by Graypoint LLC

During the third quarter, Graypoint LLC significantly expanded its investment in The Clorox Company (NYSE:CLX) by 28.0%. This growth is noted in their latest 13F filing with the Securities and Exchange Commission. Following the purchase of an additional 854 shares, Graypoint LLC now holds a total of 3,899 shares in Clorox, valued at approximately $635,000 as of the end of the quarter.

Other large investors have also adjusted their investments in Clorox. For example, Insight Folios Inc increased its holdings by 3.0% during the third quarter, bringing its total to 2,195 shares worth $358,000 after adding 63 shares. Similarly, GHP Investment Advisors Inc. enhanced its stake by 2.0% in the second quarter, accumulating a total of 3,634 shares valued at $496,000 after buying an additional 72 shares. Fiduciary Group LLC slightly raised its holdings by 0.4% during the same period, and now owns 19,050 shares worth $2,600,000 after acquiring 72 additional shares. Also, SPC Financial Inc. increased its shares by 2.2%, now owning 3,485 shares valued at $476,000 after purchasing another 75 shares. Lastly, Massmutual Trust Co. FSB ADV saw a 17.2% increase in its position during the third quarter, totaling 510 shares currently worth $83,000 after acquiring 75 more shares. Notably, institutional and hedge funds together own 78.53% of Clorox stock.

Analyst Perspectives on Clorox

Recent analysis from equity research firms has provided mixed views on Clorox shares. Citigroup increased its price target from $165.00 to $170.00, ranking the stock as “neutral” on September 6th. Deutsche Bank similarly updated their target price from $144.00 to $151.00 with a “hold” rating. In contrast, BNP Paribas has downgraded Clorox to a “strong sell” rating as of September 6th. TD Cowen changed its stance from “sell” to “hold” and revised the target price from $155.00 to $170.00. DA Davidson also raised its target from $153.00 to $171.00 while maintaining a “neutral” rating on November 4th. In total, five analysts have rated Clorox with a sell rating, while ten have designated it as hold, and one analyst has given it a buy rating. As per MarketBeat.com, the average analyst recommendation remains a “Hold” with a consensus target price of $155.00.

Clorox Stock Performance

The stock of Clorox opened at $165.20 on the last trading day. Financial metrics include a debt-to-equity ratio of 11.08, a current ratio of 1.00, and a quick ratio of 0.62. Over the past year, Clorox has traded between a low of $127.60 and a high of $169.09, with a market capitalization of $20.45 billion. The price-to-earnings ratio stands at 57.56, with a price-to-earnings growth ratio of 3.02; its beta is measured at 0.41. The company has a 50-day simple moving average of $162.14 and a 200-day simple moving average of $146.83.

On October 30th, Clorox announced its earnings results, revealing an earnings per share (EPS) of $1.86, surpassing the consensus estimate of $1.36 by $0.50. Revenue for the quarter came in at $1.76 billion, exceeding the analysts' expectations of $1.64 billion, with a year-over-year revenue increase of 27.0%. Last year, during the same quarter, Clorox reported an EPS of $0.49. Analysts project an average EPS of 6.81 for the current fiscal year.

Dividend Distribution by Clorox

The company also declared a quarterly dividend of $1.22 per share, which was distributed on November 7th to its shareholders recorded by October 23rd. The ex-dividend date was also October 23rd, leading to an annualized dividend of $4.88, translating to a dividend yield of 2.95%. Clorox's payout ratio stands at a high of 170.04%.

Insider Transactions at Clorox

Regarding insider activity, Executive Vice President Angela C. Hilt sold 1,733 shares of Clorox on September 6th, at an average price of $165.52, totaling $286,846.16. Post-transaction, she holds 13,471 shares valued at approximately $2,229,719.92, reflecting no significant change in her ownership percentage of the stock. This transaction was reported in a filing with the SEC, which can be reviewed through the regulatory agency's portal. Company insiders own 0.57% of the total shares outstanding.

The Clorox Company Overview

The Clorox Company is a global player in the manufacturing and marketing of consumer and professional products. The business operates through four main segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness sector produces various cleaning and laundry products, including brands like Clorox, Clorox2, and Scentiva, along with professional cleaning and disinfecting products under CloroxPro and Clorox Healthcare. They also offer food service items under Hidden Valley and health products such as vitamins and supplements under brands like RenewLife and NeoCell in the U.S.

Clorox, Investment, Stock